Mylan, Ethypharm Strike Deal In FazaClo Patent Spat
Mylan Pharmaceuticals Inc. has agreed to end its declaratory judgment suit against Ethypharm SA over the schizophrenia drug FazaClo, with the drug companies entering a stipulated judgment that Mylan's generic medication...To view the full article, register now.
Already a subscriber? Click here to view full article